Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen

References

• Sidhu SS, Fellouse FA. Synthetic therapeutic antibodies. Nat Chem Biol. 2006;2(12):682–17. doi:10.1038/nchembio843.
   PubMed Web of Science ®Google Scholar
• McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990;348(6301):552–54. doi:10.1038/348552a0.
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y. et al. Biophysical properties of the clinical-stage antibody landscape. Proc Natl Acad Sci USA. 2017;114(5):944–49. doi:10.1073/pnas.1616408114.
   PubMed Web of Science ®Google Scholar
• Wolf Perez AM, Sormanni P, Andersen JS, Sakhnini LI, Rodriguez-Leon I, Bjelke JR, Gajhede AJ, De Maria L, Otzen DE, Vendruscolo M. et al. In vitro and in silico assessment of the developability of a designed monoclonal antibody library. Mabs-austin. 2019;11(2):388–400. doi:10.1080/19420862.2018.1556082.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A. et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–89. doi:10.1038/s41586-021-03819-2.
   PubMed Web of Science ®Google Scholar
• Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, Wang J, Cong Q, Kinch LN, Schaeffer RD. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science. 2021;373(6557):871–76. doi:10.1126/science.abj8754.
   PubMed Web of Science ®Google Scholar
• Evans R, Clausen TM, Nora C, Cribbs AP, Denardo A, Clark AE, Garretson AF, Coker JKC, Narayanan A, Majowicz SA. et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv. 2021; 2021.10.04.463034. doi:10.1101/2021.03.22.436522.
   Google Scholar
• Lin Z, Akin H, Rao R, Hie B, Zhu Z, Lu W, Smetanin N, Verkuil R, Kabeli O, Shmueli Y. et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science. 2023;379(6637):1123–30. doi:10.1126/science.ade2574.
   PubMed Web of Science ®Google Scholar
• Abanades B, Georges G, Bujotzek A, Deane CM. ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation. Bioinformatics. 2022;38(7):1877–80. doi:10.1093/bioinformatics/btac016.
   PubMed Web of Science ®Google Scholar
• Ruffolo JA, Chu L-S, Mahajan SP, Gray JJ. Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies. Nat Commun. 2023;14(1):2389. doi:10.1038/s41467-023-38063-x.
   PubMed Web of Science ®Google Scholar
• Ruffolo JA, Sulam J, Gray JJ. Antibody structure prediction using interpretable deep learning. Patterns (N Y). 2022;3(2):100406. doi:10.1016/j.patter.2021.100406.
   PubMedGoogle Scholar
• Cohen T, Halfon M, Schneidman-Duhovny D. NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning. Front Immunol. 2022;13:958584. doi:10.3389/fimmu.2022.958584.
   PubMed Web of Science ®Google Scholar
• Anishchenko I, Pellock SJ, Chidyausiku TM, Ramelot TA, Ovchinnikov S, Hao J, Bafna K, Norn C, Kang A, Bera AK. et al. De novo protein design by deep network hallucination. Nature. 2021;600(7889):547–52. doi:10.1038/s41586-021-04184-w.
   PubMed Web of Science ®Google Scholar
• Norn C, Wicky BIM, Juergens D, Liu S, Kim D, Tischer D, Koepnick B, Anishchenko I, Baker D, Ovchinnikov S. et al. Protein sequence design by conformational landscape optimization. Proc Natl Acad Sci USA. 2021;118(11). doi:10.1073/pnas.2017228118.
   PubMed Web of Science ®Google Scholar
• Mahajan SP, Ruffolo JA, Frick R, Gray JJ. Hallucinating structure-conditioned antibody libraries for target-specific binders. Front Immunol. 2022;13:999034. doi:10.3389/fimmu.2022.999034.
   PubMed Web of Science ®Google Scholar
• Hie BL, Shanker, VR, Xu D, Bruun, TU, Weidenbacher, PA, Tang S, Wu, W, Pak, JE, Kim, PS. Efficient evolution of human antibodies from general protein language models. Nat Biotechnol. 2023;42(2):275–83
   PubMed Web of Science ®Google Scholar
• Nijkamp E, Ruffolo JA, Weinstein EN, Naik N, Madani A. ProGen2: exploring the boundaries of protein language models. Cell Syst. 2022;14(11):968–78.e3. doi:10.1016/j.cels.2023.10.002.
   Web of Science ®Google Scholar
• Ruffolo JA, Gray JJ, Sulam J. Deciphering antibody affinity maturation with language models and weakly supervised learning. 2021.
   Google Scholar
• Leem J, Mitchell LS, Farmery JHR, Barton J, Galson JD. Deciphering the language of antibodies using self-supervised learning. Patterns (N Y). 2022;3(7):100513. doi:10.1016/j.patter.2022.100513.
   PubMedGoogle Scholar
• Prihoda D, Maamary J, Waight A, Juan V, Fayadat-Dilman L, Svozil D, Bitton DA. BioPhi: a platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning. Mabs-austin. 2022;14(1):2020203. doi:10.1080/19420862.2021.2020203.
   PubMed Web of Science ®Google Scholar
• Shuai RW, Ruffolo JA, Gray JJ. Generative language modeling for antibody design. bioRxiv. 2021; 2021.12.13.472419.
   Google Scholar
• Luo S, Su Y, Peng X, Wang S, Peng J, Ma J. Antigen-specific antibody design and optimization with diffusion-based generative models. Adv Neural Inf Process Syst. 2022;35:2022.07.10.499510.
   Google Scholar
• Madani A, Krause B, Greene ER, Subramanian S, Mohr BP, Holton JM, Olmos JL, Xiong C, Sun ZZ, Socher R. et al. Large language models generate functional protein sequences across diverse families. Nat Biotechnol. 2023;41(8):1099–106. doi:10.1038/s41587-022-01618-2.
   PubMed Web of Science ®Google Scholar
• Pudžiuvelytė I, Olechnovič K, Godliauskaite E, Sermokas K, Urbaitis T, Gasiunas G, Kazlauskas D. TemStaPro: protein thermostability prediction using sequence representations from protein language models. Bioinformatics. 2023;40(4):2023.03.27.534365.
   Web of Science ®Google Scholar
• Hummer AM, Schneider C, Chinery L, Deane, CM. Investigating the volume and diversity of data needed for generalizable antibody-antigen ∆∆G prediction. bioRxiv. 2023; 2023.05.17.541222.
   Google Scholar
• Festa F, Steel J, Bian X, Labaer J. High-throughput cloning and expression library creation for functional proteomics. Proteomics. 2013;13(9):1381–99. doi:10.1002/pmic.201200456.
   PubMed Web of Science ®Google Scholar
• Hughes SR, Butt TR, Bartolett S, Riedmuller SB, Farrelly P. Design and construction of a first-generation high-throughput integrated robotic molecular biology platform for bioenergy applications. J Lab Autom. 2011;16(4):292–307. doi:10.1016/j.jala.2011.04.004.
   PubMedGoogle Scholar
• Jia B, Jeon CO. High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives. Open Biol. 2016;6(8):6(8. doi:10.1098/rsob.160196.
   Web of Science ®Google Scholar
• Razinkov VI, Treuheit MJ, Becker GW. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools. J Biomol Screen. 2015;20(4):468–83. doi:10.1177/1087057114565593.
   PubMedGoogle Scholar
• Furtmann N, Schneider M, Spindler N, Steinmann B, Li Z, Focken I, Meyer J, Dimova D, Kroll K, Leuschner WD. et al. An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics. Mabs-austin. 2021;13(1):1955433. doi:10.1080/19420862.2021.1955433.
   PubMed Web of Science ®Google Scholar
• Segaliny AI, Jayaraman J, Chen X, Chong J, Luxon R, Fung A, Fu Q, Jiang X, Rivera R, Ma X. et al. A high throughput bispecific antibody discovery pipeline. Commun Biol. 2023;6(1):380. doi:10.1038/s42003-023-04746-w.
   PubMed Web of Science ®Google Scholar
• Warszawski S, Borenstein Katz A, Lipsh R, Khmelnitsky L, Ben Nissan G, Javitt G, Dym O, Unger T, Knop O, Albeck S. et al. Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces. PLOS Comput Biol. 2019;15(8):e1007207. doi:10.1371/journal.pcbi.1007207.
   PubMed Web of Science ®Google Scholar
• Braden BC, Souchon H, Eiselé J-L, Bentley GA, Bhat TN, Navaza J, Poljak RJ. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1. J Mol Biol. 1994;243(4):767–81. doi:10.1016/0022-2836(94)90046-9.
   PubMed Web of Science ®Google Scholar
• Cauerhff A, Goldbaum FA, Braden BC. Structural mechanism for affinity maturation of an anti-lysozyme antibody. Proc Natl Acad Sci U S A. 2004;101(10):3539–44. doi:10.1073/pnas.0400060101.
   PubMed Web of Science ®Google Scholar
• Schwarz FP, Tello D, Goldbaum FA, Mariuzza RA, Poljak RJ. Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. Eur J Biochem. 1995;228(2):388–94. doi:10.1111/j.1432-1033.1995.00388.x.
   PubMedGoogle Scholar
• Tennenhouse A, Khmelnitsky L, Khalaila R, Yeshaya N, Noronha A, Lindzen M, Makowski EK, Zaretsky I, Sirkis YF, Galon-Wolfenson Y. et al. Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nat Biomed Eng. 2023;8(1):30–44. doi:10.1038/s41551-023-01079-1.
   PubMed Web of Science ®Google Scholar
• Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol. 2007;25(10):1171–76. doi:10.1038/nbt1336.
   PubMed Web of Science ®Google Scholar
• Dauparas J, Anishchenko I, Bennett N, Bai H, Ragotte RJ, Milles LF, Wicky BIM, Courbet A, de Haas RJ, Bethel N. et al. Robust deep learning–based protein sequence design using ProteinMPNN. Science. 2022;378(6615):49–56. doi:10.1126/science.add2187.
   PubMed Web of Science ®Google Scholar
• Dreyer FA, Cutting D, Schneider C, Kenlay H, Deane, CM. Inverse folding for antibody sequence design using deep learning. arXiv preprint arXiv:2310.19513. 2023.
   Google Scholar
• Abanades B, Wong WK, Boyles F, Georges G, Bujotzek A, Deane CM. ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins. Commun Biol. 2023;6(1):575. doi:10.1038/s42003-023-04927-7.
   PubMed Web of Science ®Google Scholar
• Bennett NR, Watson, JL, Ragotte, RJ, Borst, AJ, See, DL, Weidle C, Biswas R, Shrock, EL, Leung, PJ, Huang B. et al. Atomically accurate de novo design of single-domain antibodies. bioRxiv. 2024; 2024.03.14.585103.
   Google Scholar
• Dobson CL, Devine PWA, Phillips JJ, Higazi DR, Lloyd C, Popovic B, Arnold J, Buchanan A, Lewis A, Goodman J. et al. Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo. Sci Rep. 2016;6(1):38644. doi:10.1038/srep38644.
   PubMed Web of Science ®Google Scholar